What are the major opportunities in the Oncology Biomarkers market? What are the strategies for the Oncology Biomarkers market?

For detailed insights on the major opportunities and strategies in the Oncology Biomarkers market, Read More

How does the Oncology Biomarkers market relate to the overall economy and other similar markets?

For detailed insights on Oncology Biomarkers's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Oncology Biomarkers market growth? SWOT analysis of the Oncology Biomarkers market.

For detailed insights on the key dynamics influencing the Oncology Biomarkers market growth and SWOT analysis of the Oncology Biomarkers industry, Read More

Oncology Biomarkers Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Oncology Biomarkers Market Report 2026

Name: Oncology Biomarkers Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications), By End-User (Hospitals, Academic And Cancer Research Institutes, Diagnostic Laboratories) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Oncology Biomarkers Market Overview

• Oncology Biomarkers market size has reached to $17.3 billion in 2025

• Expected to grow to $33.63 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%

• Growth Driver: Rising Prevalence Of Cancer To Drive Market Growth

• Market Trend: Innovations In Oncology Biomarkers Enhance Early Detection And Monitoring Of Cancer

• North America was the largest region in 2025.

What Is Covered Under Oncology Biomarkers Market?

Oncology biomarkers refer to biological indicators, such as genes, proteins, or other molecules, that can signal the presence of cancer or its progression. They are used to diagnose cancer, predict treatment responses, and monitor disease progression or recurrence. By analyzing these biomarkers, healthcare providers can tailor personalized treatment plans for patients.

The main types of oncology biomarkers are protein biomarkers, genetic biomarkers, and others. Protein biomarkers refer to a single protein or multiple proteins used to diagnose an illness, understand prognosis, and monitor a patient's biological response to treatment. The profiling technologies are omics technologies, imaging technologies, immunoassays, bioinformatics, and others. Cancer types include breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, leukemia, ovarian cancer, liver cancer, and others. The various applications are diagnostics, research and development, prognostics, risk assessment, and others, and are mainly used in hospitals, academic and cancer research institutes, ambulatory surgical centers, and diagnostic laboratories.

Oncology Biomarkers market report bar graph

What Is The Oncology Biomarkers Market Size and Share 2026?

The oncology biomarkers market size has grown rapidly in recent years. It will grow from $17.3 billion in 2025 to $19.73 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to expansion of cancer screening programs, advancements in molecular biology research, increased availability of biomarker testing platforms, growth in oncology clinical trials, rising collaboration between research institutions and hospitals.

What Is The Oncology Biomarkers Market Growth Forecast?

The oncology biomarkers market size is expected to see rapid growth in the next few years. It will grow to $33.63 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing demand for personalized oncology therapies, expansion of AI-driven biomarker discovery, growing investments in cancer genomics, rising adoption of liquid biopsy technologies, increased focus on early cancer detection and monitoring. Major trends in the forecast period include increasing adoption of precision oncology diagnostics, rising use of genetic and protein biomarkers, growing integration of bioinformatics in biomarker analysis, expansion of companion diagnostics development, enhanced focus on personalized cancer treatment.

Book your 30 minutes free consultation with our research experts

Global Oncology Biomarkers Market Segmentation

1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types

2) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types

3) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

4) By End-User: Hospitals, Academic And Cancer Research Institutes, Diagnostic Laboratories

Subsegments:

1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers

2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)

3) By Other Biomarker Types: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers

What Is The Driver Of The Oncology Biomarkers Market?

The rising incidence of cancer is expected to propel the growth of the oncology biomarker market going forward. Cancer is a disease in which some cells of the body grow uncontrollably and slowly spread to the rest of the body. Oncological biomarkers provide more information about the type of cancer by looking at the genes, proteins, and other substances in a person's body. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising incidence of cancer is driving the growth of the oncology biomarkers industry.

Key Players In The Global Oncology Biomarkers Market

Major companies operating in the oncology biomarkers market are F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Epigenomics AG, OncoDNA SA

Global Oncology Biomarkers Market Trends and Insights

Major companies operating in the oncology diagnostics market are focusing on developing advanced biomarker-based assays to improve early cancer detection, monitor minimal residual disease (MRD), and assess patient response to therapies. Minimal residual disease refers to the small number of cancer cells that may remain in the body after treatment, which can lead to recurrence if undetected. For instance, in May 2024, Tempus, a US-based artificial intelligence and precision medicine company, launched its MRD test portfolio, including the xM test and the xM (NeXT Personal Dx) test developed by Personalis. The portfolio features both tumor-naïve and tumor-informed assays designed to detect early cancer recurrence and residual disease, as well as monitor patient response to immunotherapy. By leveraging circulating tumor biomarkers, these assays provide clinicians with sensitive and actionable insights to guide patient management.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Oncology Biomarkers Market?

In May 2023, Freenome, a US-based, privately held biotech company, acquired Oncimmune Ltd. For an undisclosed amount. This acquisition will help Freenome by providing clinical and commercial resources to complement Freenome’s frontline cancer screening efforts. Further, the acquisition will help augment Freenome’s multi-omics platform to capture a more comprehensive view of the tumor microenvironment. Oncimmune Ltd. Is a UK-based company specializing in developing immunodiagnostics, primarily focusing on immune-oncology, autoimmune disorders, and infectious diseases.

Regional Outlook

North America was the largest region in the oncology biomarkers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Oncology Biomarkers Market?

The oncology biomarkers market consists of sales of epigenetic biomarkers, metabolic biomarkers and proteomic biomarkers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oncology Biomarkers Market Report 2026?

The oncology biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Oncology Biomarkers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$19.73 billion
Revenue Forecast In 2035	$33.63 billion
Growth Rate	CAGR of 14.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Biomarker Type, Cancer Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Epigenomics AG, OncoDNA SA
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Oncology Biomarkers Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Oncology Biomarkers Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Oncology Biomarkers Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Oncology Biomarkers Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Artificial Intelligence And Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data And Cybersecurity

4.1.4 Industry 4.0 And Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Precision Oncology Diagnostics

4.2.2 Rising Use Of Genetic And Protein Biomarkers

4.2.3 Growing Integration Of Bioinformatics In Biomarker Analysis

4.2.4 Expansion Of Companion Diagnostics Development

4.2.5 Enhanced Focus On Personalized Cancer Treatment

5. Oncology Biomarkers Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Academic And Cancer Research Institutes

5.3 Diagnostic Laboratories

5.4 Ambulatory Surgical Centers

5.5 Pharmaceutical And Biotechnology Companies

6. Oncology Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncology Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Oncology Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Oncology Biomarkers Market Size, Comparisons And Growth Rate Analysis

7.3. Global Oncology Biomarkers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Oncology Biomarkers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncology Biomarkers Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncology Biomarkers Market Segmentation

9.1. Global Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types

9.2. Global Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types

9.3. Global Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

9.4. Global Oncology Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Academic And Cancer Research Institutes, Diagnostic Laboratories

9.5. Global Oncology Biomarkers Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers

9.6. Global Oncology Biomarkers Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)

9.7. Global Oncology Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers

10. Oncology Biomarkers Market Regional And Country Analysis

10.1. Global Oncology Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Oncology Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncology Biomarkers Market

11.1. Asia-Pacific Oncology Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncology Biomarkers Market

12.1. China Oncology Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncology Biomarkers Market

13.1. India Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncology Biomarkers Market

14.1. Japan Oncology Biomarkers Market Overview

14.2. Japan Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncology Biomarkers Market

15.1. Australia Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncology Biomarkers Market

16.1. Indonesia Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncology Biomarkers Market

17.1. South Korea Oncology Biomarkers Market Overview

17.2. South Korea Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oncology Biomarkers Market

18.1. Taiwan Oncology Biomarkers Market Overview

18.2. Taiwan Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oncology Biomarkers Market

19.1. South East Asia Oncology Biomarkers Market Overview

19.2. South East Asia Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oncology Biomarkers Market

20.1. Western Europe Oncology Biomarkers Market Overview

20.2. Western Europe Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oncology Biomarkers Market

21.1. UK Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oncology Biomarkers Market

22.1. Germany Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oncology Biomarkers Market

23.1. France Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oncology Biomarkers Market

24.1. Italy Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oncology Biomarkers Market

25.1. Spain Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oncology Biomarkers Market

26.1. Eastern Europe Oncology Biomarkers Market Overview

26.2. Eastern Europe Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oncology Biomarkers Market

27.1. Russia Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oncology Biomarkers Market

28.1. North America Oncology Biomarkers Market Overview

28.2. North America Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oncology Biomarkers Market

29.1. USA Oncology Biomarkers Market Overview

29.2. USA Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oncology Biomarkers Market

30.1. Canada Oncology Biomarkers Market Overview

30.2. Canada Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oncology Biomarkers Market

31.1. South America Oncology Biomarkers Market Overview

31.2. South America Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oncology Biomarkers Market

32.1. Brazil Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oncology Biomarkers Market

33.1. Middle East Oncology Biomarkers Market Overview

33.2. Middle East Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oncology Biomarkers Market

34.1. Africa Oncology Biomarkers Market Overview

34.2. Africa Oncology Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oncology Biomarkers Market Regulatory and Investment Landscape

36. Oncology Biomarkers Market Competitive Landscape And Company Profiles

36.1. Oncology Biomarkers Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Oncology Biomarkers Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Oncology Biomarkers Market Company Profiles

36.3.1. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Oncology Biomarkers Market Other Major And Innovative Companies

Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems

38. Global Oncology Biomarkers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oncology Biomarkers Market

40. Oncology Biomarkers Market High Potential Countries, Segments and Strategies

40.1 Oncology Biomarkers Market In 2030 - Countries Offering Most New Opportunities

40.2 Oncology Biomarkers Market In 2030 - Segments Offering Most New Opportunities

40.3 Oncology Biomarkers Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Oncology Biomarkers Market, Overview Of Key Products - Product Examples

Table 2: Global Oncology Biomarkers Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Oncology Biomarkers Market, Supply Chain Analysis

Table 4: Global Oncology Biomarkers Market, Major Raw Material Providers

Table 5: Global Oncology Biomarkers Market, Major Resource Providers

Table 6: Global Oncology Biomarkers Market, Major Manufacturers (Suppliers)

Table 7: Global Oncology Biomarkers Market, Major Distributors And Channel Partners

Table 8: Global Oncology Biomarkers Market, Key Technologies & Future Trends

Table 9: Global Oncology Biomarkers Market, Major Trends

Table 10: Global Oncology Biomarkers Market, Major End Users

Table 11: Global Oncology Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Oncology Biomarkers Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Oncology Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Oncology Biomarkers Market - TAM, US$ Billion, 2025

Table 15: Global Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Oncology Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Oncology Biomarkers Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Oncology Biomarkers Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Oncology Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Oncology Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Oncology Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Oncology Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Oncology Biomarkers Market - Company Scoring Matrix

Table 98: F Hoffmann-La Roche AG Financial Performance

Table 99: Novartis AG Financial Performance

Table 100: Thermo Fisher Scientific Inc. Financial Performance

Table 101: Abbott Laboratories Financial Performance

Table 102: Merck KGaA Financial Performance

Table 103: Global Oncology Biomarkers Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Oncology Biomarkers Market, Competitive Dashboard

Table 105: Global Oncology Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Oncology Biomarkers Market Size Gain ($ Billion), Segmentation By Biomarker Type, 2025 – 2030

Table 107: Global, Oncology Biomarkers Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

Table 108: Global, Oncology Biomarkers Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Oncology Biomarkers Market, Overview Of Key Products - Product Examples

Figure 2: Global Oncology Biomarkers Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Oncology Biomarkers Market, Supply Chain Analysis

Figure 4: Global Oncology Biomarkers Market, Major Raw Material Providers

Figure 5: Global Oncology Biomarkers Market, Major Resource Providers

Figure 6: Global Oncology Biomarkers Market, Major Manufacturers (Suppliers)

Figure 7: Global Oncology Biomarkers Market, Major Distributors And Channel Partners

Figure 8: Global Oncology Biomarkers Market, Key Technologies & Future Trends

Figure 9: Global Oncology Biomarkers Market, Major Trends

Figure 10: Global Oncology Biomarkers Market, Major End Users

Figure 11: Global Oncology Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Oncology Biomarkers Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Oncology Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Oncology Biomarkers Market - TAM, US$ Billion, 2025

Figure 15: Global Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Oncology Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Oncology Biomarkers Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Oncology Biomarkers Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Oncology Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Oncology Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Oncology Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Oncology Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Oncology Biomarkers Market - Company Scoring Matrix

Figure 98: F Hoffmann-La Roche AG Financial Performance

Figure 99: Novartis AG Financial Performance

Figure 100: Thermo Fisher Scientific Inc. Financial Performance

Figure 101: Abbott Laboratories Financial Performance

Figure 102: Merck KGaA Financial Performance

Figure 103: Global Oncology Biomarkers Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Oncology Biomarkers Market, Competitive Dashboard

Figure 105: Global Oncology Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Oncology Biomarkers Market Size Gain ($ Billion), Segmentation By Biomarker Type, 2025 – 2030

Figure 107: Global, Oncology Biomarkers Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

Figure 108: Global, Oncology Biomarkers Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

2025 Analysis: Opportunities and Risks in the Evolving Healthcare Chromatography Analyzers Market

Future Projections: Healthcare Smart Card Reader Market to Reach $3.12 Billion by 2029 at 17.8% CAGR

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Biomarkers Market Report 2026 - Global Outlook – By Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Disease (Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, ...

Oncology Biomarkers Market Report 2026 - Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,...

Cancer Biomarker Market Report 2026 - Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Profiling Technologies (Omics Technologies, Immunoassay, Bioinformatics, Cytoge...

Clinical Biomarkers Market Report 2026 - Global Outlook – By Offering (Product, Service), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immuno...

Clinical Oncology Next Generation Sequencing Market Report 2026 - Global Outlook – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible...

Biomarker Clinical Phase Outsourcing Services Market Report 2026 - Global Outlook – By Type (Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Other Biomarker Types), By Service Type (Bio...

Biomarker Discovery Outsourcing Services Market Report 2026 - Global Outlook – By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints), By Discovery Phase (Biomarker Identification,...

Frequently Asked Questions

How big is the Oncology Biomarkers Market?

The Oncology Biomarkers market was valued at $17.3 billion in 2025, increased to $19.73 billion in 2026, and is projected to reach $33.63 billion by 2030.

What is the Oncology Biomarkers market growth?

The global Oncology Biomarkers market is expected to grow at a CAGR of 14.3% from 2026 to 2035 to reach $33.63 billion by 2035.

Who are the key players in Oncology Biomarkers market?

Some Key Players in the Oncology Biomarkers market Include, F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Epigenomics AG, OncoDNA SA .

What is the anticipated growth trend for the Oncology Biomarkers market?

Major trend in this market includes: Innovations In Oncology Biomarkers Enhance Early Detection And Monitoring Of Cancer. For further insights on this market. request a sample here

Which region has the most growth potential in the Oncology Biomarkers market?

North America was the largest region in the oncology biomarkers market in 2025. The regions covered in the oncology biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.